SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman; Anthony D Harris; Ramin Sedaghat Herati; Florian Krammer; Alberto Mantovani; Maria Rescigno; Mohammad M Sajadi; Viviana Simon

doi:10.1016/j.ebiom.2021.103401

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

EBioMedicine. 2021 Jun:68:103401. doi: 10.1016/j.ebiom.2021.103401. Epub 2021 May 26.

Authors

Matthew Frieman¹, Anthony D Harris², Ramin Sedaghat Herati³, Florian Krammer⁴, Alberto Mantovani⁵, Maria Rescigno⁶, Mohammad M Sajadi⁷, Viviana Simon⁸

Affiliations

¹ Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States. Electronic address: MFrieman@som.umaryland.edu.
² Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States. Electronic address: aharris@som.umaryland.edu.
³ New York University School of Medicine, New York City, NY, United States. Electronic address: Ramin.Herati@nyulangone.org.
⁴ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: florian.krammer@mssm.edu.
⁵ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy; The William Harvey Research Institute, Queen Mary University, London, United Kingdom. Electronic address: Alberto.Mantovani@humanitasresearch.it.
⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy. Electronic address: maria.rescigno@hunimed.eu.
⁷ Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States; Global Virus Network, Baltimore, Maryland, United States. Electronic address: msajadi@ihv.umaryland.edu.
⁸ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: viviana.simon@mssm.edu.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Neutralizing / biosynthesis
Antibodies, Neutralizing / blood
Antibodies, Viral / biosynthesis
Antibodies, Viral / blood
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / administration & dosage*
COVID-19 Vaccines / supply & distribution
Health Policy
Humans
Immunization Schedule*
Immunization, Secondary*
Mass Vaccination / methods*
Mass Vaccination / organization & administration
Mass Vaccination / statistics & numerical data
Pandemics*
SARS-CoV-2 / immunology*
Survivors*
Vaccination / methods*

Substances

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines

Publication types

MeSH terms

Substances

Grants and funding